Journal of Peptide Science
J. Peptide Sci. 2006; 12: 279–290
Published online 2 September 2005 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/psc.720
Detection of new amino acid sequences of alamethicins F30
by nonaqueous capillary electrophoresis–mass spectrometry
ARNDT PSUREK,a CHRISTIAN NEUSÜß,b THOMAS DEGENKOLB,c HANS BRÜCKNER,c ELVIRA BALAGUER,d
DIANA IMHOFe and GERHARD K. E. SCRIBAa *
a
University of Jena, School of Pharmacy, Department of Pharmaceutical Chemistry, Philosophenweg 14, D-07743 Jena, Germany
Bruker Daltonik GmbH, Leipzig, Permoserstrasse 15, D-04318 Leipzig, Germany
c University of Giessen, Interdisciplinary Research Center, Department of Food Sciences, Heinrich-Buff-Ring 26-32, D-35392 Giessen, Germany
d University of Barcelona, Department of Analytical Chemistry, Av. Diagonal 647, 08028 Barcelona, Spain
e University of Jena, Department of Biochemistry, Philosophenweg 12, 07743 Jena, Germany
b
Received 19 May 2005; Accepted 25 July 2005
Abstract: The microheterogeneous alamethicin F30 (ALM F30) isolated from the fermentation of Trichoderma viride strain NRRL
3199 was analyzed by nonaqueous capillary electrophoresis coupled to electrospray ion-trap mass spectrometry (ESI-IT-MS)
and electrospray time-of-flight mass spectrometry (ESI-TOF-MS). Tandem ESI-IT-MS was used for elucidation of the amino acid
sequence based on the fragmentation pattern of selected parent ions. The MS/MS spectra using the [M + 3H]3+ or [M + 2H]2+
ions as precursor ions displayed the respective b- and the y-type fragments resulting from cleavage of the particularly labile
Aib–Pro bond. The MS3 of these fragments generated the b acylium ion series, as well as internal fragment ion series. Eleven
amino acid sequences were identified, characterized by the exchange of Ala to Aib in position 6, Gln to Glu in positions 7 or 19 as
well as the loss of the C-terminal amino alcohol. In addition, two truncated pyroglutamyl peptaibols were found. Overall, seven
new sequences are reported compared to earlier LC–MS studies. The composition of the components was confirmed by on-line
ESI-TOF-MS detection. Mass accuracy well below 5 ppm was observed. Quantification of the individual components was achieved
by a combination of UV and TOF-MS detection. Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
Keywords: nonaqueous capillary electrophoresis; mass spectrometry detection; peptaibiotics; polypeptide antibiotics;
peptaibols; alamethicin F30; α-aminoisobutyric acid; pyroglutamic acid
INTRODUCTION
Alamethicins are 20-residue peptaibol peptides isolated
from the culture broth of the mold Trichoderma
viride [1,2] exhibiting interesting physicochemical and
biological activities, such as the formation of voltagedependent ion channels in bilayer lipid membranes, as
well as antibiotic activities [3]. The voltage-dependent
ion channel formation by alamethicin can be described
by the dipole flip-flop gating model of Boheim and Jung
[4,5] based on electrical field–induced transbilayer
orientational movements of single molecules. The
conductance states of the ion conductivity pores vary
with the number of parallelly arranged α-helices.
Recently, single pore states could be stabilized by Cterminal conjugation of alamethicin with fullerene or a
membrane-anchoring lipopeptide [6].
Peptaibols are linear peptides composed of 5–20
amino acids [7]. These compounds are exclusively biosynthesized by fungicolous, plant or entomopathogenic fungi, thus assuming potential importance in the parasitic life cycle of the producers [8]. The
nonribosomal biosynthesis includes nonproteinogenic
amino acids, in particular α-aminoisobutyric acid (Aib).
* Correspondence to: G. K. E. Scriba, School of Pharmacy, Department
of Pharmaceutical Chemistry, University of Jena, Philosophenweg 14,
07743 Jena, Germany; e-mail: gerhard.scriba@uni-jena.de
Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
Aib residues are conformationally restricted and favor
the formation of 310 - and α-helical structures. Peptaibols are amphiphilic because of the acylated, nonpolar
N -terminus and the more polar, C-terminal amino alcohol. The name ‘peptaibol’ reflects the characteristics of
this class of compounds being peptides containing Aib
and a C-terminal amino alcohol.
Depending on the fermentation conditions, T. viride
produces the neutral alamethicins F50 (ALM F50) or the
acidic peptaibols alamethicins F30 (ALM F30) [2]. Both
are microheterogeneous mixtures of closely related
sequential analogs that possess a phenylalaninol (Pheol
or Fol) at the C-terminus, while the N -terminus is
acetylated. ALM F50 and ALM F30 differ in the amino
acid in position 18, which is the (neutral) glutamine in
the case of ALM F50 and the (acidic) glutamate residue
in the case of ALM F30 [2,9]. The structure of ALM F30
has been confirmed by total synthesis [10].
Tandem mass spectrometry, especially electrospray
ionization (ESI) or matrix-assisted laser desorption
ionization (MALDI) coupled to quadrupole, ion-trap
(IT) or time-of-flight (TOF) mass analyzers have been
proven useful for structural studies of peptaibols [8].
The separation of the individual components of ALM
F50 and ALM F30 has been achieved by reversedphase high performance liquid chromotography (HPLC)
and the structure of the components was determined
280
PSUREK ET AL.
by HPLC–ESI-MSn by Brückner and coworkers [2].
The acidic ALM F30 and the neutral ALM F50
were isolated from the culture broth by XAD-2
column chromatography and separated by silica gel
chromatography. The composition of the individual
peptaibols was subsequently determined by HPLC–ESIMSn . According to this study, ALM F30 consists of
two major components that differ in the amino acid in
position 6 (Ala or Aib) and eight minor components.
Nonaqueous capillary electrophoresis (NACE) using
solvents such as methanol, acetonitrile or N methylformamide, instead of water, for the preparation
of the background electrolytes is increasingly applied
to analytical problems [11]. Important parameters such
as efficiency and selectivity can be effectively modified
when aqueous buffers are replaced by nonaqueous electrolyte solutions. Organic solvents favor interactions
that are weak in aqueous media. Furthermore, the solubility and stability of many analytes and additives
are enhanced in nonaqueous solvents. Moreover, nonaqueous solvents may be preferable for electrochemical
detection as well as for electrospray ionization mass
spectrometry (ESI-MS) detection [12].
Traditionally, peptides as hydrophilic compounds
are analyzed by capillary electrophoresis (CE) using
aqueous background electrolytes. However, beneficial
effects of organic solvents for the separation of
hydrophobic peptides in aqueous CE media have been
described. For example, an acidic aqueous buffer
containing 20% 2-propanol as organic modifier was
applied to the analysis of isomeric N -palmitoylated
bradykinin and O-palmitoylated gonadorelin as well
as (cysteinyl-4,5)-palmitoylated peptide SP-C14 [13].
Hodges and coworkers described the separation of 18residue α-helical amphipathic peptide diastereomers by
capillary zone electrophoresis with highly concentrated
(up to 400 mM) perfluorinated acid ion-pairing reagents
in aqueous solution [14]. The authors attributed
the successful separation to conformational changes
between the peptide diastereomers and differences in
hydrophobicity of the nonpolar face of the amphipathic
α-helices and their interactions with the hydrophobic
anionic ion-pairing reagent. On-line NACE–MS of
hydrophobic peptides gramicidin S and bacitracin has
been demonstrated [15]. The separations were achieved
in an acetonitrile/methanol-based system containing
ammonium acetate and formic acid. ESI-MS allowed
the determination of three minor components in the
case of gramicidin S and one minor component in the
case of bacitracin. The current status of CE–MS for the
analysis of proteins and peptides including NACE–MS
has been recently summarized [16].
The separation of peptaibols by CE has not
been described previously. However, because of their
lipophilic nature, NACE seems to be a suitable electromigration technique for this class of compounds.
Thus, the present study was conducted in order to
Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
evaluate the potential of NACE coupled to MS for the
analysis of peptaibols including the determination of
their amino acid sequence. The natural ALM F30 was
selected as model peptaibols because these compounds
contain a glutamic acid residue in position 18 that can
be deprotonated for electrophoretic analysis.
MATERIALS AND METHODS
Chemicals
Methanol, acetonitrile, 2-propanol, dichloromethane (all HPLC
grade quality), ammonium acetate and silica gel 60 (mesh
size <0.063 mm) were purchased from VWR International
(Darmstadt, Germany). Ammonium formate was obtained from
Sigma-Aldrich (Steinheim, Germany). Ammonium acetate and
ammonium formate were dried overnight in a desiccator over
silica before use. ALM F30 was isolated from fermentations of
T. viride strain NRRL 3199 as described previously [2].
The peptides Pyr-Aib-Val-Aib-Gly-Leuol and Glu-Aib-ValAib-Gly-Leuol were synthesized by solid-phase synthesis using
the Fmoc strategy for the assembly of the peptide on the
solid support [17,18]. The Fmoc-protected terminating amino
alcohol was directly anchored onto the 2-chlorotrityl chloride
resin. Activation of the sterically hindered Aib was achieved
using tetramethylfluoroformamidinium hexafluorophosphate
(TFFH) as coupling reagent, as described by Carpino et al.
[18]. The peptides were purified by preparative HPLC, and
their identity was confirmed by MALDI-MS.
Capillary electrophoresis
CE with UV detection was performed on a Beckman
P/ACE 5510 instrument (Beckman Coulter, Krefeld, Germany)
equipped with a diode-array detector at 25 ° C using 50-µm i.d.
fused-silica capillaries (Polymicro Technologies, Phoenix, AZ,
USA) with an effective length of 50 cm and a total length of
57 cm. UV detection was carried out at 215 nm at the cathodic
end of the capillary. Sample solutions were introduced at the
anodic end by hydrodynamic injections at a pressure of 0.5 psi
for 3 s.
CE–MS experiments were performed using a Hewlett
Packard 3D CE instrument (Agilent Technologies, Waldbronn,
Germany). Separations were performed at 25 ° C in 50-µm i.d.
fused-silica capillaries with a length of 57 cm by application of
a separation voltage of 30 kV (sprayer grounded). A pressure
of 50 mbar for 4 s was used for sample injection.
New capillaries were rinsed for 30 min with 0.1 M sodium
hydroxide, 5 min with water and 10 min with methanol
followed by the separation medium for 10 min. Between
analyses, the capillary was flushed with the running buffer
for 2 min. When not in use, it was washed with the respective
solvent and then stored under dry conditions.
Electrospray Ionization Mass Spectrometry
On-line coupling of the CE instrument to the mass spectrometer detector was achieved with an Agilent coaxial sheath-liquid
sprayer interface (Agilent Technologies, Palo Alto, CA, USA).
The sheath liquid, 2-propanol : water (1 : 1, v/v) containing 1%
formic acid, was supplied at a flow rate of 4 µl/min by a
J. Peptide Sci. 2006; 12: 279–290
ANALYSIS OF ALAMETHICIN F30 BY NACE–ESI-MS
syringe pump (Cole-Palmer, Vernon Hill, IL, USA). Nebulizer
gas pressure was set to 2–3 psi. All ESI-MS experiments were
carried out in positive ionization mode at 4500 V.
ESI-IT-MS measurements were performed using an iontrap mass spectrometer Esquire HCT (Bruker Daltonik,
Bremen, Germany). Mass spectra were acquired from m/z
200 to 1500 in the scanning mode and automatic switching
between MS and MSn . Ions were scanned at a speed of 8300
m/z per s in the MS mode in order to achieve sufficient
resolution for charge attribution of triply charged peptides.
The enhanced auto-MSn settings were optimized to get as
many MSn spectra over a selected time period as possible.
This was achieved by scanning at 26 000 m/z per s and
active exclusion after two spectra per mass in a given time
window of 0.5 min. MS2 and MS3 spectra were acquired
selecting one (MS2 ) or two (MS3 ) most abundant precursors
or by adding preferred masses in the case of follow-up
experiments.
ESI-TOF-MS measurements were performed on an orthogonal TOF mass spectrometer micrOTOF (Bruker Daltonik,
Bremen, Germany). The mass spectrometer operated in an
m/z range 200–1500.
Data processing was performed by DataAnalysis software
(Version 3.0; Bruker Daltonik). The peptide MS fragments are
labeled according to standard rules [19,20].
281
RESULTS AND DISCUSSION
NACE Separation of ALM F30
NACE separation of the microheterogeneous ALM F30
was evaluated in methanol, acetonitrile and mixtures of these solvents using ammonium acetate–
and ammonium formate–based electrolytes. The solvents are widely used in NACE because of their
appropriate dielectric constant–to-viscosity ratio [11].
While electrolyte solutions in acetonitrile and acetonitrile–methanol mixtures did not afford satisfactory
separations because of the low mobility of the analytes in these solvents, good separation selectivity was
obtained using methanol-based electrolytes. 12.5 mM
ammonium formate in methanol yielded six separated
peaks using UV detection (data not shown).
Subsequent NACE–ESI-MS was performed using
this background electrolyte and a sheath liquid
consisting of 1% formic acid in a 1 : 1 mixture
of 1-propanol and water, which provided stable
spray and protonation conditions for the peptaibols.
Figure 1 shows the base peak electropherogram of
Figure 1 Extracted ion electropherograms of NACE with full-scan ESI-IT-MS detection. (A) Base peak electropherogram.
(B–E) Mass traces of the different b13 fragments (see Table 2). (F) [M + 2H]2+ pseudomolecular ion of the Pyr-containing peptides.
Experimental conditions: capillary dimensions, 57 cm × 50 µm i.d.; running electrolyte, 12.5 mM ammonium formate in methanol;
separation voltage, 30 kV (18 µA); for ESI-MS conditions see Experimental Section. Sample concentration: 500 µg/ml in methanol.
Peak identity: numbers refer to peptide sequences shown in Table 1.
Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
J. Peptide Sci. 2006; 12: 279–290
282
PSUREK ET AL.
ALM F30 (Figure 1A) as well as electropherograms
of selected mass traces of the characteristic b13
fragment ions obtained with full-scan ESI-IT-MS
(Figure 1B–E). The identification of the individual
components and the determination of their amino
acid sequences are discussed below. The extracted
ion electropherogram (EIE) of the b13 fragments
at m/z 1189.9 (Figure 1B) and 1203.8 (Figure 1D)
as well as at m/z 1190.7 (Figure 1C) and 1204.8
(Figure 1E) with mass differences of 14 Da correspond
to the exchange of Ala by Aib in the peptaibols.
Most of the respective compounds comigrated, as
the mass difference of 14 Da is apparently not
large enough to be translated into electrophoretic
separations of otherwise identical peptaibols with
molecular masses of about 1900–1950 Da. The EIE
of m/z 706 (Figure 1F) corresponds to the doubly
charged pseudomolecular [M + 2H]2+ ions of truncated
pyroglutamyl (Pyr) peptaibols.
in the positive ion mode from specific precursor ions
such as the triply and doubly charged pseudomolecular [M + 3H]3+ and [M + 2H]2+ ions for MS2 spectra and
from the b13 and y7 fragments, respectively, in the case
of the MS3 spectra. Figures 2 and 3 show the ESI-ITMS3 spectra of [Aib6 ] ALM F30 (3) and [desAA(1–6),Pyr7]
ALM F30 (7), respectively, as examples.
The MS spectra show the doubly and triply charged
pseudomolecular ions, [M + 2H]2+ or [M + 3H]3+ , as
well as the corresponding ammonium adducts in some
cases. Moreover, b13 - and y7 -fragments are generated,
resulting from fragmentation of the particularly labile
Aib–Pro bond. The tertiary amide bond undergoes a
preferential cleavage, leading to an N -terminal acylium
ion (b-type fragment) and a diprotonated C-terminal ion
(y-type fragment) [21]. These characteristic fragments
were also obtained in the ESI-IT-MS full-scan mode
(without MSn ) illustrating the facile cleavage of the
Aib–Pro bond. Other peptaibols such as harzianins [21],
stilboflavins [22], trichotoxins [23] and trichofumins
[24] exhibit similar fragmentation patterns in ESI-MS.
The MS2 spectra using the [M + 3H]3+ or [M + 2H]2+ ions
as precursor ions displayed the respective b- and the
y-type fragments resulting from cleavage of the Aib–Pro
bond. The selection of the appropriate precursor ions
allowed the identification and amino acid sequence
determination also in case of comigrating substances.
In the case of the 20- and 19-residue peptaibols, the
triply charged pseudomolecular ions [M + 3H]3+ were
selected as the precursor ions for the MS2 analysis
Amino Acid Sequence Determination
Table 1 summarizes the amino acid sequences of ALM
F30 as determined by NACE–ESI-MS analysis. A different numbering as compared to the nomenclature
applied in Ref. 2 of the ALM F30 peptides is used for
reasons of simplicity. The mass fragments and molecular ions of all components of ALM F30 determined in
this study are compiled in Table 2. The majority of the
diagnostic ions was identified via NACE–ESI-IT-MSn
Table 1 Sequences and relative quantities (%) of the ALM F30 peptides characterized by NACE–ESI-MS in the
microheterogeneous mixture. Exchanged amino acid positions are highlighted in bold letters. Abbreviations of the amino
acids are according to the one-letter code, Ac – acetyl, U – Aib, Pyr – pyroglutamic acid. The denotation of the ALM F30 peptides
identified by HPLC–MS [2] is listed in the third column
Nomenclature
in Ref. 2
1 ALM F50
2 [desAA(1–6),Pyr7 ]
ALM F50
3 [Aib6 ] ALM F30
4 ALM F30
5 [Glu19 ] ALM F30
6 [Aib6 ,Glu19 ] ALM
F30
7 [desAA(1–6),Pyr7 ]
ALM F30
8 [desPheol] ALM
F30
9 [Aib6 ,desPheol]
ALM F30
10 [Aib6 ,Glu7 ] ALM
F30
11 [Glu7 ] ALM F30
a
F50/5
—
F30/7
F30/3
—
—
%
1 2 3 4
5
6
7
8
9 10 11 12 13 14 15 16 17 18 19
—a Ac U P U A U A Q U V
0.4
Pyr U V
38.9
51.0
1.4
1.2
Ac
Ac
Ac
Ac
U
U
U
U
P
P
P
P
U
U
U
U
A
A
A
A
U
U
U
U
U
A
A
U
20
U
U
G
G
L
L
U
U
P
P
V
V
U
U
U
U
Q
Q
Q
Q
Fol
Fol
V
V
V
V
U
U
U
U
G
G
G
G
L
L
L
L
U
U
U
U
P
P
P
P
V
V
V
V
U
U
U
U
U
U
U
U
E
E
E
E
Q
Q
E
E
Fol
Fol
Fol
Fol
Pyr U V
U
G
L
U
P
V
U
U
E
Q
Fol
Q
Q
Q
Q
U
U
U
U
—
2.9
—
0.6 Ac U P U A U A
Q
U V
U
G
L
U
P
V
U
U
E
Q
—
0.7 Ac U P U A U U
Q
U V
U
G
L
U
P
V
U
U
E
Q
—
1.3 Ac U P U A U U
E
U V
U
G
L
U
P
V
U
U
E
Q
Fol
F30/6
1.7 Ac U P U A U A
E
U V
U
G
L
U
P
V
U
U
E
Q
Fol
Not quantified, because the uncharged ALM F50 comigrates with the EOF.
Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
J. Peptide Sci. 2006; 12: 279–290
Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
Table 2 Fragment ions, pseudomolecular ions and adducts of pseudomolecular ions (m/z ratio) of ALM F30 determined by NACE–ESI-MS. The numbering of the components
corresponds to Table 1
Diagnostic ion
1
3
4
5
6
10
11
225.1
310.2
381.2
466.3
537.3
665.4
750.4
849.5
934.5
1189.7
595.8
774.4
756.4
623.3
495.3
367.2
282.2
256.2
341.2
440.3
525.3
653.4
724.4
809.5
880.5
982.1
990.6
655.1
660.8
225.1
310.2
381.2
466.3
551.3
679.4
764.4
863.5
948.5
1203.7
602.9
775.4
757.4
624.3
496.3
367.2
282.1
256.2
341.2
440.3
525.3
653.4
738.4
823.5
894.5
989.6
998.1
660.1
665.8
225.1
310.2
381.2
466.3
537.3
665.4
750.4
849.5
934.5
1189.7
595.8
775.4
757.4
624.3
496.3
367.2
282.2
n.d.
341.2
440.3
525.3
653.4
724.4
809.5
880.5
982.6
991.1
655.4
661.1
225.1
310.2
381.2
466.3
537.3
665.4
750.4
n.d.
934.5
1189.7
595.8
776.4
758.4
625.3
496.3
367.2
282.2
256.2
341.2
440.3
525.3
653.4
724.4
809.5
880.5
983.1
991.6
655.7
661.4
225.1
310.2
381.2
466.3
551.3
679.4
764.4
n.d.
948.5
1203.7
602.9
776.4
758.4
625.3
496.3
367.2
282.2
256.2
341.2
440.3
525.3
653.4
738.4
823.5
894.5
990.1
998.6
660.4
666.1
225.1
310.2
381.2
466.3
551.3
680.4
765.4
864.5
949.5
1204.7
603.4
775.4
757.4
624.3
496.3
367.2
282.2
256.2
341.2
440.3
525.3
654.4
739.4
824.5
895.5
990.0
998.5
660.4
666.1
225.1
310.2
381.2
466.3
537.3
666.3
751.4
850.5
935.5
1190.7
596.3
775.4
757.4
624.3
496.3
367.2
282.2
256.2
341.2
440.3
525.3
654.4
725.4
810.5
881.5
983.1
991.6
655.7
661.4
n.d. – not determined.
b2
b3
b4
b5
b6
b7
—
—
—
—
—
y7
[y7 − H2 O]
y7 b13
y7 b12
y7 b11
y7 b10
b7 y10
b7 y11
b7 y12
b7 y13
—
—
—
—
[M + 2H]2+
[M + NH4 + H]2+
[M + 3H]3+
[M + NH4 + 2H]3+
Diagnostic ion
m/z
2
7
n.d.
296.2
381.2
438.2
551.3
636.4
—
—
—
—
—
774.4
756.4
623.3
495.3
367.2
282.2
256.2
341.2
440.3
525.3
—
—
—
—
705.4
713.9
n.d.
n.d.
197.1
296.2
381.2
438.2
551.3
636.4
—
—
—
—
—
775.4
757.4
624.3
496.3
367.2
282.2
256.2
341.2
440.3
525.3
—
—
—
—
705.9
714.4
n.d.
n.d.
b2
b3
b4
b5
b6
b7
b8
b9
b10
b13
[b13 + 2H]2+
y6
[y6 − H2 O]
—
y6 b18
y6 b17
y6 b16
b13 y9
b13 y10
b13 y11
b13 y12
b13 y13
b13 y14
b13 y15
b13 y16
[M + 2H]2+
[M + NH4 + H]2+
[M + 3H]3+
[M + NH4 + 2H]3+
m/z
8
9
225.1
310.2
381.2
466.3
537.3
665.4
750.4
849.5
934.5
1189.7
595.8
642.3
624.3
—
496.3
367.2
282.2
256.2
341.2
440.3
525.3
653.4
724.4
809.5
880.5
916.0
924.5
611.0
616.7
225.1
310.2
381.2
466.3
551.3
679.4
764.4
863.5
948.5
1203.7
602.9
642.3
624.3
—
496.3
367.2
282.2
256.2
341.2
440.3
525.3
653.4
738.4
823.5
894.5
923.0
931.5
615.7
621.4
ANALYSIS OF ALAMETHICIN F30 BY NACE–ESI-MS
283
J. Peptide Sci. 2006; 12: 279–290
b2
b3
b4
b5
b6
b7
b8
b9
b10
b13
[b13 + 2H]2+
y7
[y7 − H2 O]
y7 b19
y7 b18
y7 b17
y7 b16
b13 y10
b13 y11
b13 y12
b13 y13
b13 y14
b13 y15
b13 y16
b13 y17
[M + 2H]2+
[M + NH4 + H]2+
[M + 3H]3+
[M + NH4 + 2H]3+
Diagnostic ion
m/z
284
PSUREK ET AL.
Figure 2
Figure 3
ESI-IT-MSn (n = 1–3) of [Aib6 ] ALM F30 (3).
ESI-IT-MSn (n = 1–3) of [desAA(1–6),Pyr7 ] ALM F30 (7).
Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
J. Peptide Sci. 2006; 12: 279–290
ANALYSIS OF ALAMETHICIN F30 BY NACE–ESI-MS
(Figure 2). MS2 generated the b13 and the y7 fragment
or, in case of the desPheol ALM F30 peptides, the y6
fragment (data not shown). The b13 fragment is detected
as a doubly charged ion. The MS3 of the diprotonated
b13 fragment ([b13 + 2H]2+ ) generated the b2 – b10
acylium ion series, as well as the monoprotonated
internal fragments b13 y10 – b13 y17 (Table 2). The Cterminal sequences of the peptides were determined
by MS3 of the y7 fragment and, in the case of the
desPheol ALM F30 peptides, of the y6 fragment. The
resulting internal ion series (y7 b19 – y7 b16 ) are formed
by the cleavage of C-terminal residues while the charge
remains at the N -terminus. Loss of water from the
y7 fragment leads to a y7 – H2 O fragment ion in the
MS3 spectra. The C-terminal position of Pheol was
concluded from the mass difference of 150 + 1 Da from
diprotonated y7 and monoprotonated y7 b19 fragments.
A fragmentation scheme is presented in (Figure 4)
showing the series of diagnostic ions and internal
fragments used for sequence determination of [Aib6 ]
ALM F30 (3).
The signals of the b2 ions were recorded at m/z
225 corresponding to the fragment Ac-Aib-Pro. The
internal fragments b13 y10 (m/z 256) and y7 b16 (m/z
282) correspond to the Gly-Leu-Aib and the Pro-ValAib tripeptides, respectively. The sequences of these
three fragments were derived from earlier HPLC–MS
investigations of ALM F30 [2,9] assuming sequence
analogy.
The sequences of the two pyroglutamyl peptaibols
(14-residue peptides) [desAA(1–6),Pyr7] ALM F50 (2)
and [desAA(1–6),Pyr7 ] ALM F30 (7) were concluded from
MS3 analysis of the b7 and y7 fragments generated by
the cleavage of the Aib-Pro bond of the pseudomolecular
ion [M + 2H]2+ (Figure 3 for [desAA(1–6),Pyr7 ] ALM
F30). The internal fragments of b7 are the b2 − b7
acylium ion series and the monoprotonated fragments
b7 y10 − b7 y13 analogous to the b13 fragment of the 20residue ALM F30 peptaibols. The y7 fragment formed
the y7 b10 − y7 b13 internal fragment series. In contrast to
Figure 4
285
the 20-residue ALM F30 peptides, the sequence of the
b7 y10 fragment at m/z 256 corresponding to the GlyLeu-Aib tripeptide could be confirmed by the b5 − b7
fragment ions.
Pandey et al. reported the formation of pyroglutamyl peptide fragments in an electron-impact mass
spectrometry study of ALM F30 [9]. However, the formation of pyroglutamyl peptides during the ESI process has not been described. In order to evaluate
the fragmentation pattern of Glu versus Pyr peptides, two model peptides containing reduced C-termini
with the amino acid sequences Glu-Aib-Val-Aib-GlyLeuol (Glu-hexapeptide) and Pyr-Aib-Val-Aib-Gly-Leuol
(Pyr-hexapeptide) were synthesized and subjected to
NACE–ESI-MS. The ESI-IT-MS3 spectra of the two
model hexapeptides displayed the respective b-type and
the y-type ion series. The [M + H]+ ions were selected as
the precursor ions, and the fragment ions are listed in
Table 3. In the spectrum of the Glu-hexapeptide, the b2 ,
b3 and b4 fragments were detected and also additional
signals corresponding to the loss of water from the
b2 − b4 fragments. These fragments have identical m/z
values as the b2 − b4 fragments of the Pyr-hexapeptide
so that formation of Pyr peptides in the ESI source
can be assumed. However, the Glu-hexapeptide can
be clearly distinguished by the presence of the b2 − b5
fragments 18 mass units higher than those of the Pyrhexapeptide. In addition, both peptides have different
electrophoretic mobilities. Thus, it can be concluded
that the truncated Pyr peptaibol components in ALM
F30 are in fact present in the investigated sample
and not an artefact generated in the ESI ion source
because the compounds did not display the respective
18-mass-units-higher fragments in the spectra. Interestingly, [desAA(1–6),Pyr7 ] ALM F50 (2) displayed a low
anodic mobility despite the fact that this compound
should be neutral as it does not contain a charged
amino acid. Apparently, under the present NACE conditions, a partial negative charge is induced. Moreover,
the anodic mobility of [desAA(1–6),Pyr7] ALM F50 (2)
Fragmentation scheme of [Aib6 ] ALM F30 (3). Fragments were generated by ESI-IT-MSn (n = 1–3).
Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
J. Peptide Sci. 2006; 12: 279–290
286
PSUREK ET AL.
was confirmed by the anodic mobility of the Pyr model
hexapeptide.
The amino acid composition of the ALM F30 components obtained by NACE–ESI-IT-MSn was confirmed by
NACE–ESI-TOF-MS analysis. Doubly or triply charged
molecular ions were the most abundant ions in the
spectra. Fragmentation was not observed (data not
shown). The high resolution of the TOF mass analyzer
allowed the analysis of the isotope pattern as shown
in Figure 5 for the [M + 3H]3+ ion of [desPheol] ALM
F30 (8) and the [M + 2H]2+ ion of [desAA(1–6),Pyr7 ]
ALM F30 (7) including a comparison of the experimental spectra with the simulated isotope pattern obtained
Table 3 Fragment ions, pseudomolecular ions and adducts
of pseudomolecular ions (m/z ratio) of the model hexapeptides
Glu-Aib-Val-Aib-Gly-Leuol (Glu-hexapeptide) and Pyr-Aib-ValAib-Gly-Leuol (Pyr-hexapeptide)
Ion
b2
b3
b4
b5
y2
y3
y4
y5
[b2 − H2 O]
[b3 − H2 O]
[b4 − H2 O]
[M + H]+
m/z
Glu-hexapeptide
Pyr-hexapeptide
215.1
314.2
399.2
456.2
157.1
242.2
341.2
426.3
197.1
296.2
381.2
573.3
197.1
296.2
381.2
438.2
157.1
242.2
341.2
426.3
—
—
—
555.3
by the Bruker DataAnalysis software. In both examples, the measured isotope pattern was consistent with
the calculated isotope pattern, thus confirming the elemental composition, i.e. the amino acid composition of
the identified components. This approach was applied
to the confirmation of the amino acid composition of
all compounds. Table 4 summarizes the experimentally
determined monoisotopic m/z values using ALM F30 as
mass calibrant compared to the respective calculated
values. With the exception of the neutral ALM F50,
mass accuracy was clearly below 5 ppm for the doubly
charged ions and below 2 ppm for the triply charged
ions. The relative inaccuracy found for ALM F50 may be
due to the fact that this compound migrates essentially
with the electroosmotic flow (EOF).
Except for the neutral components ALM F50 (1)
and [desAA(1–6),Pyr7 ] ALM F50 (2), the compounds
possess a Glu residue in position 18 and carry a
negative charge under the applied NACE conditions.
Not considering [desAA(1–6),Pyr7] ALM F30 (7), the
Glu18 derivatives can be divided into pairs characterized
by the exchange of Ala by Aib in position 6. This
exchange is characteristic for many peptaibol peptides
[7]. Compared to the pair of the major components ALM
F30 (4) and [Aib6 ] ALM F30 (3), the other pairs are
characterized by an additional carboxy group resulting
from the exchange of Gln in position 19 to Glu,
i.e. [Glu19 ] ALM F30 (5) and [Aib6 ,Glu19 ] ALM F30
(6), the exchange of Gln to Glu in position 7, i.e.
[Glu7 ] ALM F30 (11) and [Aib6 ,Glu7 ] ALM F30 (10),
or loss of the C-terminal phenylalaninol, i.e. [desPheol]
ALM F30 (8) and [Aib6 ,desPheol] ALM F30 (9). Except
for [Glu7 ] ALM F30 (11) and [Aib6 ,Glu7 ] ALM F30
(10), which are well separated, the peptaibols of the
respective pairs comigrate as the mass difference of
Figure 5 Measured (A, C) and calculated (B, D) isotope pattern of [desPheol] ALM F30 (A, B) and [desAA(1–6),Pyr7 ] ALM
F30 (C, D).
Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
J. Peptide Sci. 2006; 12: 279–290
ANALYSIS OF ALAMETHICIN F30 BY NACE–ESI-MS
287
Table 4 Calculated and measured m/z ratios of the pseudomolecular ions observed in ESI-TOF-MS
Molecular
formula
1
2
3
4
5
6
7
8
9
10
11
ALM F50
[des(1–6),Pyr7 ] ALM F50
[Aib6 ] ALM F30
ALM F30
[Glu19 ] ALM F30
[Aib6 ,Glu19 ] ALM F30
[des(1–6),Pyr7 ] ALM F30
[desPheol] ALM F30
[Aib6 ,desPheol] ALM F30
[Aib6 ,Glu7 ] ALM F30
[Glu7 ] ALM F30
C92 H151 N23 O24
C67 H108 N16 O17
C93 H152 N22 O25
C92 H150 N22 O25
C92 H149 N21 O26
C93 H151 N21 O26
C67 H107 N15 O18
C83 H139 N21 O25
C84 H141 N21 O25
C93 H151 N21 O26
C92 H149 N21 O26
Monoisotopic
molecular
mass (Da)
1962.09
1408.77
1977.08
1963.07
1964.05
1978.06
1409.75
1830.00
1844.01
1978.06
1964.05
14 Da caused by the exchange of Ala versus Aib is
not sufficient to be translated into CE separations
of peptaibols with masses of approximately 1950 Da
under the experimental conditions applied.
Peptaibiotics terminating in a free amino acid or
amide instead of a C-terminal 2-amino alcohol residue
have been described previously. They comprise XR 586
(Gly at the C-terminus) [25]; trichobrachins TB I A, B, C,
and D (Gln at the C-terminus) as well as trichobrachins
II A, C, and D (Val at the C-terminus) [26]; lipohexin
(β-Ala at the C-terminus) [27,28], pseudokonin KL III
(Pro-NH2 at the C-terminus) [29] and cephaibols P and
Q (Ser at the C-terminus) [30].
N -terminal pyroglutamic acid (Pyr) containing peptaibols have not yet been reported. Whether [desAA(1–6),
Pyr7 ] ALM F50 (2) and [desAA(1–6),Pyr7 ] ALM F30
(7) are naturally occurring compounds or artifacts
caused by the workup or enzymatic degradation of
peptaibols in the fermentation process remains to be
answered. In order to estimate the possibility of the
formation during workup, ALM F30 was heated for
41 h at 100 ° C in the crystalline state as well as in
dichloromethane/methanol (1 : 1, v/v) in the presence
of an equal amount of silica gel G 60 for 4, 8 and 24 h
at 70 ° C in a closed vial simulating the chromatographic
workup [2] of the sample. The samples were analyzed
by LC–MS and CE. Neither treatment increased the
amount of the truncated pyroglutamyl peptides compared to untreated samples. Thus, formation of these
peptides during workup appears to be unlikely. In addition, when specifically searching for the mass trace of
the [desAA(1–6),Pyr7 ] ALM F30 (7) in LC–MS, the compound could also be detected in samples of ALM F30
described in Ref. 2.
To the best of our knowledge, this is the first report on
the occurrence of Pyr as a constituent of fungal peptides
in nature. Literature search did not reveal any previous
Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
m/z monoisotopic mass
[M + 2H]2+
Measured
Calculated
982.0784
705.4107
989.5723
Calibrant
983.0562
990.0609
705.9031
916.0177
923.0305
990.0634
983.0557
982.0724
705.4112
989.5722
982.5644
983.0564
990.0642
705.9032
916.0198
923.0276
990.0642
983.0564
m
(ppm)
+6.1
−0.7
+0.1
—
−0.2
−3.3
−0.1
−2.3
+3.1
−0.8
−0.7
[M + 3H]3+
Measured
Calculated
655.0483
—
660.0507
Calibrant
655.7075
660.3798
—
611.0148
615.6873
660.3797
655.7066
655.0507
—
660.0506
655.3787
655.7067
660.3786
—
611.0156
615.6875
660.3786
655.7067
m
(ppm)
−3.7
—
+0.2
—
+1.2
+1.8
—
−1.3
−0.3
+1.7
−0.2
publications regarding the isolation of peptide-bound
Pyr from a fungal source. Pyr is rather widespread
as an N -terminal constituent of peptides obtained
from bacteria, plants, vertebrates and invertebrates.
For example, the enzymatic production of Pyr by
thermophilic lactic acid bacteria in Italian cheeses
has been described [31,32]. Pyr has been reported
as a constituent of antifungal peptides from the bark
of Eucommia ulmoides [33], as a constituent of an
adipokinetic hormone from the corpora cardiaca of the
butterfly Vanessa cardui (Lepidoptera, Nymphalidae)
[34], in gomesin, a defensive peptide found in the
hemocytes of the tarantula spider Acanthoscurria
gomesiana (Theraphosidae) [35], from the abdominal
ganglia of the snail Aplysia californica [36], as well as
from the hemolymph of the shrimp Penaeus vannamei
(Decapoda) [37]. The N -terminus of neurotensins from
the European green frog Rana ridibunda also contains
a Pyr [38] as does the N -terminus of bradykinin
potentiating peptides (BPPs) from the crude venom
of the viper Bothrops jararaca [39]. Biosynthetically,
Pyr peptides originate from glutaminyl peptides by
the action of pyroglutamyl cyclases. Currently, more
than 100 pyroglutamyl cyclase-type genes can be
found in genomic databases such as BLAST (Basic
Local Alignment Tool, National Center for Biotechnology
Information), including fungal sources. Thus, the
possibility of the formation of the truncated peptaibols
before extraction can also not be generally ruled out at
present. Future studies have to be performed in order
to unequivocally prove the origin of the truncated Pyr
peptaibols by T . viride.
Further confirmation of the identity of [desAA(1–6),
Pyr7 ] ALM F30 (7) and [desPheol] ALM F30 (8) may
be derived from the so-called sigma value that
represents a calculated parameter based on the true
isotopic pattern (TIP ; Bruker Daltonik). It considers
J. Peptide Sci. 2006; 12: 279–290
288
PSUREK ET AL.
the mass and the relative intensities of all isotopes. For
both substances, the calculated elemental composition
based on the isotopic pattern of the [M + 2H]2+ ion
belongs to the top 10% of possible hits.
The microheterogeneous ALM F30 isolated from
a fermentation broth has previously been analyzed
by HPLC–MS and 10 components have been identified [2]. Except for one compound (peptaibol F30/6
in Ref. 2 corresponding to [Glu7 ] ALM F30 (11) in
this study) all components possess only one chargeable function with Glu in position 19. Further amino
acid exchanges reported in [2] include Val to Aib or
Leu in position 9, Leu to Val in position 12 and
Aib to Val in position 17 besides the exchange of
Ala with Aib in position 6, which was also found
for the peptaibols described in the present study.
Seven of these peptaibols were not identified by
NACE–ESI-IT-MS. However, careful analysis of the ESITOF-MS runs revealed that the peptaibols with the
sequences AcUPUAUAQUUUGLUPVUUEQFol (F30/1 in
Ref. 2) and AcUPUAUAQUVUGVUPVUUEQFol (F30/2
in Ref. 2) apparently comigrate with the major components ALM F30 (4) and [Aib6 ] ALM F30 (3) in NACE.
Other peptaibols identified in Ref. 2 have identical
masses as the major components or masses differing
by only 14 Da. As described above, a mass difference of
14 Da between peptides of approximately 1950 Da may
not always be sufficient to be translated into a separation by CE. Thus, it appears very likely that most of the
minor peptaibol components described in Ref. 2 comigrate with the major components of ALM F30 in NACE.
Owing to the large excess of the major component,
it was not possible to properly select the appropriate
precursor ions for amino acid sequence elucidation of
comigrating minor components by NACE–ESI-MSn .
In contrast, the majority of minor peptaibol components identified by NACE–MS possesses a second
carboxy function due to Gln/Glu exchange or loss of
the C-terminal Pheol. Except for [Glu7 ] ALM F30 (component F30/6 in Ref. 2), these compounds were not
detected in the earlier HPLC–MS study. Apparently,
ALM F30 peptaibols possessing only one carboxy function are separated more efficiently by HPLC, while components with two carboxy functions can be analyzed
better by NACE. This illustrates the complementarity
of both techniques due to their different separation
principles.
Quantification of ALM F30 Components
The relative amounts of the respective peptaibol
peptides in a heterogeneous mixture is required in
order to judge the relevance of structural variations of
individual peptides, in particular, when bioactivities are
discussed. In the present NACE assay, the composition
cannot be directly obtained from the electropherograms
because of the comigration of compounds. Thus, the
amount of the identified ALM F30 components in the
microheterogeneous mixture was estimated from the
NACE-UV traces at 215 nm in combination with the
NACE–ESI-TOF-MS results. The relative amount of
comigrating or incompletely separated peptides was
calculated on the basis of the corrected peak area
(peak area divided by the migration time) obtained
from the EIE of characteristic isotopic signals of
the pseudomolecular [M + 2H]2+ and [M + 3H]3+ ions,
while the absolute amount of comigrating peptides
was calculated from the corrected peak area obtained
from the NACE-UV trace. Only peptide fragments with
similar charges and masses were chosen for the relative
Figure 6 Quantification of (A) [desPheol] ALM F30 (8) and [Aib6 ,des Pheol], ALM F30 (9) and (B) [Glu19 ] ALM F30 (5), [Aib6 ,Glu19 ]
ALM F30 (6), [Glu7 ] ALM F30 (11) and [Aib6 ,Glu7 ] ALM F30 (10) by NACE–ESI-TOF-MS. The mass traces shown result from the
addition of the unambiguously identified isotope signals of the respective analytes.
Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
J. Peptide Sci. 2006; 12: 279–290
ANALYSIS OF ALAMETHICIN F30 BY NACE–ESI-MS
quantification, so that comparable ionization yields
using ESI can be assumed for the respective analytes.
Careful selection of the correct m/z values is important
because signal overlapping by ammonium adducts
of comigrating peptides occurs. Figure 6A shows the
EIE of [desPheol] ALM F30 (8) and [Aib6 ,desPheol]
ALM F30 (9). The integration of the peaks resulted
in a quantitative relationship of 1.00 : 1.26. The
quantification of the other comigrating substances
[Glu19 ] ALM F30 (5) and [Aib6 ,Glu19 ] ALM F30 (6)
as well as [Glu7 ] ALM F30 (11) and [Aib6 ,Glu7 ] ALM
F30 (10) based on the EIE is shown in Figure 6B.
Note that the positionally isomeric peptides 5 and
11 form identical pseudomolecular ions as do the
positionally isomeric peptides 6 and 10. The resulting
quantitative relationship for these four peptides is
1.66 : 1.36 : 1.00 : 1.34. The relative amount of the
pyroglutamyl peptides and of the pair ALM F30
(4)/[Aib6 ] ALM F30 (3) was calculated in a similar
manner.
The results of the quantitative analysis are listed in
Table 1. In accordance with the results obtained by
Brückner and coworkers for ALM F30 using HPLC–MS
[2], the main components ALM F30 (4) and [Aib6 ] ALM
F30 (3) comprise about 90% of the ALM F30 peptides.
The unusual compound [desAA(1–6),Pyr7 ] ALM F30 (7)
was present at a level of about 3% while all other
minor components were below 2%. The neutral ALM
F50 is transported by the EOF. The quantification of
analytes comigrating with the EOF is difficult because
of signal quenching by impurities transported by the
EOF. Therefore, ALM F50 was not quantified.
CONCLUSIONS
The components of ALM F30 isolated from fermentations of T. viride were analyzed by NACE–ESI-IT-MS
and NACE–ESI-TOF-MS. A total of 11 compounds were
identified. These are characterized by the well-known
Ala/Aib exchange in position 6 as well as additional
Gln/Glu exchanges in positions 7 or 19, as well as
the loss of the C-terminal Pheol residue. Additionally,
two truncated pyroglutamyl derivatives were detected
which have not been described for peptaibols from fungal sources before.
Compared to an earlier study on ALM F30 by
HPLC–MS [2], the present results are in agreement
with regard to the structure and content of the major
components ALM F30 and [Aib6 ] ALM F30. However,
the discrepancy concerning the minor components is
evident. Most of the minor components described in
the HPLC study were not detected by NACE–ESI-ITMS. This may be explained by the fact that the mass
differences of ±14 Da between compounds in many
cases are not sufficient to translate into a separation
in CE. On the other hand, most of the compounds
Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
289
found by NACE–MS were not identified by HPLC–MS.
These components are characterized by an additional
carboxy group caused by the exchange to Gln versus
Glu or loss of the C-terminal amino alcohol. Apparently,
the additional charge makes such compounds more
suitable for CE analysis while they were ‘missed’
by HPLC. This demonstrates that HPLC and CE
are complementary techniques due to the different
separation mechanisms. For complete characterization
of complex peptide mixtures, both techniques should
be applied.
Acknowledgements
We are indebted to Dr Harald Bocker (Jena) and
Prof. em. Dr Detlef Gröger (Halle/Saale) for valuable
discussions on the occurrence of pyroglutamic acid in
fungal peptides and microbial sources.
REFERENCES
1. Meyer CE, Reusser F. A polypeptide antibacterial agent isolated
from Trichoderma viride. Experienta 1967; 23: 85–86.
2. Kirschbaum J, Krause C, Winzheimer RK, Brückner H. Sequences
of alamethicins F30 and F50 reconsidered and reconciled. J. Pept.
Sci. 2003; 9: 799–809.
3. Duclohier H, Wróblewski H. Voltage-dependent pore formation and
antimicrobial activity by alamethicin and analogues. J. Membr. Biol.
2001; 184: 1–12.
4. Boheim G, Hanke W, Jung G. Alamethicin pore formation: voltage
dependent flip-flop of α-helix dipoles. Biophys. Struct. Mech. 1983;
9: 181–191.
5. Menestrina G, Voges KP, Jung G, Boheim G. Voltage-dependent
channel formation by rods of helical polypeptides. J. Membr. Biol.
1986; 93: 111–132.
6. Jung G, Redemann T, Meder S, Hirsch A, Boheim G. Template-free
self-assembling fullerene and lipopeptide conjugates of alamethicin
form voltage-dependent ion channels of remarkable stability and
activity. J. Pept. Sci. 2003; 9: 784–798.
7. Whitmore L, Chugh JK, Snook CF, Wallace BA. The peptaibol
database: a sequence and structure resource. J. Pept. Sci. 2003; 9:
663–665.
8. Degenkolb T, Berg A, Gams W, Schlegel B, Gräfe U. The occurence
of peptaibols and structurally related peptaibiotics in fungi and
their mass spectrometric identification via diagnostic fragment
Ions. J. Pept. Sci. 2003; 9: 666–678.
9. Pandey RC, Cook CJ, Rinehart KL. High resolution and field
desorption mass spectrometry studies and revised structures of
alamethicins I and II. J. Am. Chem. Soc. 1977; 99: 8469–8483.
10. Schmitt H, Jung G. Total synthesis of the α-helical eicosapeptide
antibiotic alamethicin. Liebigs Ann. Chem. 1985; 321–344.
11. Riekkola M-L. Recent advances in nonaqueous capillary
electrophoresis. Electrophoresis 2002; 23: 3865–3883.
12. Matysik F-M. Special aspects of detection methodology in
nonaqueous capillary electrophoresis. Electrophoresis 2002; 23:
400–407.
13. Weinmann W, Maier C, Baumeister K, Przybylski M, Parker CE,
Tomer KB. Isolation of hydrophobic lipoproteins in organic solvents
by pressure-assisted capillary electrophoresis for subsequent
mass spectrometric characterization. J. Chromatogr. 1993; 648:
251–256.
14. Popa TV,
Mant CT,
Chen Y,
Hodges RS.
Capillary
zone
electrophoresis of small α-helical diastereomeric peptide pairs
J. Peptide Sci. 2006; 12: 279–290
290
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
PSUREK ET AL.
with anionic ion-pairing reagents. J. Chromatogr. A 2004; 1043:
113–122.
Yang Q, Benson LM, Johnson KL, Naylor S. Analysis of lipophilic
peptides and therapeutic drugs: on-line-nonaqueous capillary
electrophoresis-mass spectrometry. J. Biochem. Biophys. Methods
1999; 38: 103–121.
Stutz H.
Advances
in
the
analysis
of
proteins
and
peptides by capillary electrophoresis with matrix-assisted
laser desorption/ionization and electrospray-mass spectrometry
detection. Electrophoresis 2005; 26: 1254–1290.
Nguyen H-H, Imhof D, Kronen M, Schlegel B, Härtl A, Gräfe U,
Gera L, Reissmann S. Synthesis and biological evaluation of
analogues of the peptaibol ampullosporin A. J. Med. Chem. 2002;
45: 2781–2787.
Carpino LA, Beyermann M, Wenschuh H, Bienert M. Peptide
synthesis via amino acid halides. Acc. Chem. Res. 1996; 29:
268–274.
Roepstorff P, Fohlmann J. Proposal for a common nomenclature for
sequence ions in mass spectra of peptides. Biomed. Mass Spectrom.
1984; 11: 601.
Biemann K. Nomenclature for peptide fragment ions (positive ions).
Methods Enzymol. 1990; 193: 886–887.
Rebuffat S, Goulard C, Bodo B. Antibiotic peptides from
Trichoderma harzianum: harzianins HC, proline-rich 14-residue
peptaibols. J. Chem. Soc. Perkin Trans. 1 1995; 1849–1855.
Jaworski A, Brückner H. Sequences of polypeptide antibiotics
stilboflavins, natural peptaibol libraries of the mold Stilbella
flavipes. J. Pept. Sci. 2001; 7: 433–447.
Jaworski A, Brückner H. Detection of new sequences of
peptaibol antibiotics trichotoxins A-40 by on-line liquid
chromatography–electrospray ionization mass spectrometry. J.
Chromatogr. A 1999; 862: 179–189.
Berg A, Grigoriev PA, Degenkolb T, Neuhof T, Härtl A, Schlegel B,
Gräfe U. Isolation, structure elucidation and biological activities of
trichofumins A, B, C and D, new 11 and 13mer peptaibols from
Trichoderma sp. HKI 0276. J. Pept. Sci. 2003; 9: 810–816.
Sharman GJ, Try AC, Williams DH, Ainsworth AM, Beneyto R,
Gibson TM, McNicholas C, Renno DV, Robinson N, Wood KA,
Wrigley SK. Structural elucidation of XR586, a peptaibol-like
antibiotic from Acremonium persicium. Biochem. J. 1986; 320:
723–728.
Brückner H, Kripp M, Kieß M. Polypeptide antibiotics trichovirin
and trichobrachin: sequence determination and total synthesis.
Chem. Pept. Proteins 1993; 5/6: 357–373.
Heinze S, Ritzau M, Ihn W, Schlegel B, Dornberger K, Fleck WF,
Zerlin M, Christner C, Gräfe U, Küllertz G, Fischer G. Lipohexin, a
new inhibitor of prolyl endopeptidase from Moeszia lindtneri (HKI0096) and Paecilomyces sp. (HKI-0055; HKI-0096). I. Screening,
isolation and structure elucidation. J. Antibiotics 1997; 50:
379–383.
Copyright 2005 European Peptide Society and John Wiley & Sons, Ltd.
28. Christner C, Zerlin M, Gräfe U, Heinze S, Küllertz G, Fischer G.
Lipohexin, a new inhibitor of prolyl endopeptidase from Moeszia
lindtneri (HKI-0054) and Paecilomyces sp. (HKI-0055; HKI-0096). II.
Inhibition activity and specificity. J. Antibiotics 1997; 50: 384–389.
29. Rebuffat S, Goulard C, Hlimi S, Bodo B. Two unprecedented
natural Aib-peptides with the (Xaa-Yaa-Aib-Pro) motif and
an unusual C-terminus: Structures. Membrane modifying and
antibacterial properties of pseudokinins KL III and KL VI from the
fungus Trichoderma pseudokoningii. J. Pept. Sci. 2000; 6: 519–533.
30. Schiell M, Hofmann J, Kurz M, Schmidt FR, Vertesy L, Vogel M,
Wink J, Seibert G. Cephaibols, new peptaibol antibiotics with
antihelmintic properties from Acremonium tubakii DSM 12774. J.
Antibiotics 2001; 54: 220–233.
31. Mucchetti G, Locci F, Gatti M, Neviani E, Addeo F, Dossena A,
Marchelli R. Pyroglutamic acid in cheese: Presence, origin, and
correlation with ripening time of grana padano cheese. J. Dairy Sci.
2000; 83: 659–665.
32. Mucchetti G, Locci F, Massara P, Vitale R, Neviani E. Production
of pyroglutamic acid by thermophilic lactic acid bacteria in hardcooked mini-cheeses. J. Dairy Sci. 2002; 85: 2489–2496.
33. Huang R-H, Xiang Y, Liu X-Z, Zhang Y, Hu Z, Wang D-C. Two novel
antifungal peptides distinct with a five-disulfide motif from the bark
of Eucommia ulmoides Oliv. FEBS Lett. 2002; 521: 87–90.
34. Köllisch GV, Lorenz MW, Kellner R, Verhaert PD, Hoffmann KH.
Structure elucidation and biological activity of an unusual
adipokinetic hormone from corpora cardiaca of the butterfly,
Vanessa cardui. Eur. J. Biochem. 2000; 267: 5502–5508.
35. Silva PI, Daffre S, Bulet P. Isolation and characterization of
gomesin, an 18-residue cysteine-rich defense peptide from
the spider Acanthoscurria gomesiana hemocytes with sequence
similarities to horseshoe crab antimicrobial peptides of the
tachylepsin family. J. Biol. Chem. 2000; 275: 33 464–33 470.
36. Garden RW, Moroz TP, Gleeson JM, Floyd PD, Li L, Rubakhin SS,
Sweedler J. Formation of N-pyroglutamyl peptides from N-Glu and
N-Gln precursors in Aplysia neurons. J. Neurochem. 1999; 72:
676–681.
37. Destoumieux D, Bulet P, Loew D, Dorsselaer AV, Rodriguez J,
Bachère E. Penaeidins, a new family of antimicrobial peptides
isolated from the shrimp Penaeus vannamei (Decapoda). J. Biol.
Chem. 1997; 272: 28 398–28 406.
38. Desrues L, Tonon M-C, Leprince J, Vaudry H, Conlon JM.
Isolation, primary structure, and effects on α-melanocytestimulating hormone release of frog neurotensin. Endocrinology
1998; 139: 4140–4146.
39. Ianzer D, Konno K, Marques-Porto R, Portaro FCV, Stöcklin R, de
Camargo ACM, Pimenta DC. Identification of five new bradykinin
potentiating peptides (BPPs) from Bothrops jararaca crude venom
by using electrospray ionization tandem mass spectrometry after a
two-step liquid chromatography. Peptides 2004; 25: 1085–1092.
J. Peptide Sci. 2006; 12: 279–290